Differential diagnosis of IgM MGUS and WM according to B-lymphoid infiltration by morphology and flow cytometry

Clinical Lymphoma, Myeloma and Leukemia

Volumn 11, Issue 1, 2011, Pages 93-95

  Ocio, Enrique M ^a,b   Del Carpio, Daniel ^a   Caballero, Álvaro ^a   Alonso, Jennifer ^a   Paiva, Bruno ^a   Pesoa, Roberto ^a   Villaescusa, Teresa ^a   López Anglada, Lucía ^a   Vidriales, Belén ^a   García Sanz, Ramón ^a  

^a Centro de Investigacion del Cancer   (Spain)

^b CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; CANCER INFILTRATION; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; FLOW CYTOMETRY; HUMAN; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MORPHOLOGY; WALDENSTROEM MACROGLOBULINEMIA;

EID: 79953701356     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.3816/CLML.2011.n.017     Document Type: Conference Paper

References (18)

1. Jaffe ES, Harris NL, Stein H, et al. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press. 2001.
2. Owen RG, Treon SP, Al Katib A, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 2003; 30:110-5. (Pubitemid 36506291)
3. Kyle RA, Benson J, Larson D, et al. IgM monoclonal gammopathy of undetermined significance and smoldering Waldenstrom's macroglobulinemia. Clin Lymphoma Myeloma 2009; 9:17-8.
4. Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346:564-9. (Pubitemid 34438817)
5. McMaster ML, Caporaso N. Waldenstrom macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition. Br J Haematol 2007; 139:663-71. (Pubitemid 350115717)
6. Schop RF, Van Wier SA, Xu R, et al. 6q deletion discriminates Waldenstrom macroglobulinemia from IgM monoclonal gammopathy of undetermined significance. Cancer Genet Cytogenet 2006; 169:150-3. (Pubitemid 44382607)
7. Baldini L, Goldaniga M, Guffanti A, et al. Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system. J Clin Oncol 2005; 23:4662-8. (Pubitemid 46224068)
8. Owen RG, Parapia LA, Higginson J, et al. Clinicopathological correlates of IgM paraproteinemias. Clin Lymphoma 2000; 1:39-43.
9. Facon T, Brouillard M, Duhamel A, et al. Prognostic factors in Waldenstrom's macroglobulinemia: a report of 167 cases. J Clin Oncol 1993; 11:1553-8. (Pubitemid 23228262)
10. Dimopoulos MA, Panayiotidis P, Moulopoulos LA, et al. Waldenstrom's macroglobulinemia: clinical features, complications, and management. J Clin Oncol 2000; 18:214-26.
11. Gobbi PG, Bettini R, Montecucco C, et al. Study of prognosis in Waldenstrom's macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utility. Blood 1994; 83:2939-45.
12. Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood 2008; 111:3941-67.
13. Ocqueteau M, Orfao A, Almeida J, et al. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Am J Pathol 1998; 152:1655-65. (Pubitemid 28275024)
14. Perez-Persona E, Vidriales MB, Mateo G, et al. New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells. Blood 2007; 110:2586-92. (Pubitemid 47523182)
15. San Miguel JF, Vidriales MB, Ocio E, et al. Immunophenotypic analysis of Waldenstrom's macroglobulinemia. Semin Oncol 2003; 30:187-95.
16. Ocio EM, Hernandez JM, Mateo G, et al. Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma. Clin Lymphoma 2005; 5:241-5. (Pubitemid 40614234)
17. Owen RG. Developing diagnostic criteria in Waldenstrom's macroglobulinemia. Semin Oncol 2003; 30:196-200. (Pubitemid 36506308)
18. Pangalis GA, Kyrtsonis MC, Kontopidou FN, et al. Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders. Semin Oncol 2003; 30:201-5. (Pubitemid 36506309)